ALK produces sterile injectable formulations for use in allergy vaccines. These formulations must pass strict quality control checks before being released on the market. FORCE Technology supports ALK in identifying particles that ALK's quality assurance team finds when visually inspecting injectable formulat...
U.S. FDA Approves Label Expansion for ALK's ODACTRA® (House Dust Mite Allergen Tablet) for Sublingual Use as Immunotherapy to Now Include Children with House Dust Mite Allergy Feb 28, 2025 ALK Announces U.S. FDA Approval of New AccuTest™ Allergy Skin Testing Devices for Optimized ...
In the second line, I tend to repeat testing to evaluate what molecular targets may be appropriate for targeted therapy. I end up using lorlatinib more often. My concern moving forward, having seen the data on brigatinib in the second line, is that lorlatinib is not well tolerated. Hav...
1. A method of treating allergy or alleviating symptoms of allergy comprising oromucosal administration of the pharmaceutical product A pharmaceutical product suitable for administration of allergen comprising a fast-dispersing, non-compressed solid dosage form suitable for oromucosal administration including: ...
Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden Stephanie Mindus Department of Research and Education, Faculty of Medicine and Health, Örebro University, Örebro, Sweden Mats G. Karlsson School of Health Sciences, Örebro University, Ö...
the FDA; CBER reference provided for extract manufactures to standardize against and label their product with resulting in a biopotency label of AI or BAU (Allergy Units or Bioequivalent Allergy Units, see FDA DOCKET NO. 94N-00121 (1993) “Methods of the allergenics products testing Laboratory...